{"id":"artelac","rwe":[],"tags":[],"trials":[],"_chembl":null,"aliases":["Carbomer 0.2%"],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":null,"ecosystem":[],"_scrapedAt":"2026-03-28T04:54:52.105Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT07485959","phase":"NA","title":"The Effect of NP-2006 on Sleep Quality and Health","status":"COMPLETED","sponsor":"Hanpoong Nature Pharm Co., Ltd.","startDate":"2023-05-12","conditions":"Sleep Disorder (Disorder)","enrollment":48},{"nctId":"NCT07495852","phase":"PHASE3","title":"Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant","status":"RECRUITING","sponsor":"Glaukos Corporation","startDate":"2026-02-17","conditions":"Glaucoma","enrollment":510},{"nctId":"NCT06299319","phase":"PHASE1","title":"Feasibility, Clinical Effects, and Safety of Psilocybin-assisted Psychotherapy for Treatment-resistant OCD","status":"RECRUITING","sponsor":"Centre for Addiction and Mental Health","startDate":"2024-09-01","conditions":"Obsessive-Compulsive Disorder","enrollment":10},{"nctId":"NCT07243275","phase":"PHASE4","title":"SYSTANE® PRO vs. MIEBO™ in Dry Eye Disease","status":"RECRUITING","sponsor":"Indiana University","startDate":"2026-02-18","conditions":"Dry Eye Disease (DED)","enrollment":260},{"nctId":"NCT06544694","phase":"PHASE3","title":"A Study to Investigate the Effect of 0.003% AR-15512 on Subjects With Dry Eye Disease","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2024-10-08","conditions":"Dry Eye Disease","enrollment":80},{"nctId":"NCT06365853","phase":"PHASE2","title":"A Study of Ocular Toxicity Evaluation and Mitigation During Treatment With Mirvetuximab Soravtansine in Participants With Recurrent Ovarian Cancer With High Folate Receptor-Alpha Expression","status":"RECRUITING","sponsor":"AbbVie","startDate":"2024-07-29","conditions":"Recurrent Ovarian Cancer, Folate Receptor-Alpha Positive","enrollment":100},{"nctId":"NCT04149210","phase":"PHASE3","title":"FLuorometholone as Adjunctive MEdical Therapy for TT Surgery (FLAME) Trial","status":"COMPLETED","sponsor":"Massachusetts Eye and Ear Infirmary","startDate":"2021-08-19","conditions":"Trachomatous Trichiasis (TT), Eye Diseases, Eyelid Diseases","enrollment":2410},{"nctId":"NCT07490054","phase":"PHASE1","title":"Intestinal Microbiota Transplantation in Patients With Chronic Heart Failure","status":"RECRUITING","sponsor":"Melana Yuzefpolskaya, MD","startDate":"2025-09-01","conditions":"Chronic Heart Failure","enrollment":40},{"nctId":"NCT05319730","phase":"PHASE1, PHASE2","title":"A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2023-05-16","conditions":"Esophageal Squamous Cell Carcinoma","enrollment":230},{"nctId":"NCT02938520","phase":"PHASE3","title":"Study to Evaluate the Efficacy, Safety, and Tolerability of Long-acting Intramuscular Cabotegravir and Rilpivirine for Maintenance of Virologic Suppression Following Switch From an Integrase Inhibitor in HIV-1 Infected Therapy Naive Participants","status":"ACTIVE_NOT_RECRUITING","sponsor":"ViiV Healthcare","startDate":"2016-10-27","conditions":"HIV Infections","enrollment":631},{"nctId":"NCT07482085","phase":"PHASE3","title":"Efavirenz for the Treatment of Creutzfeldt-Jakob Disease","status":"NOT_YET_RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2026-03","conditions":"Creutzfeldt-Jakob Disease","enrollment":246},{"nctId":"NCT06089317","phase":"NA","title":"Traditional Chinese Medicine Ultrasonic Atomization Treatment for Dry Eye Disease","status":"COMPLETED","sponsor":"Chinese University of Hong Kong","startDate":"2024-07-28","conditions":"Dry Eye Syndromes","enrollment":200},{"nctId":"NCT05577910","phase":"NA","title":"Vectored Thermal Pulsation, Intense Pulsed Light, and Eyelid Warm Compress Therapies for MGD","status":"COMPLETED","sponsor":"Chinese University of Hong Kong","startDate":"2022-10-08","conditions":"Meibomian Gland Dysfunction","enrollment":374},{"nctId":"NCT06819046","phase":"","title":"Improved Efficacy of Selective Laser Trabeculoplasty With the Addition of Rocklatan Post-treatment vs Artificial Tears Post-treatment","status":"COMPLETED","sponsor":"Colorado Ophthalmology Associates PC","startDate":"2025-02-14","conditions":"Glaucoma","enrollment":70},{"nctId":"NCT06660290","phase":"PHASE3","title":"A Study to Evaluate 0.003% AR-15512 Safety and Drop Attributes","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2025-01-15","conditions":"Dry Eye Disease","enrollment":55},{"nctId":"NCT06792903","phase":"EARLY_PHASE1","title":"YM-101 Eye Drops in the Treatment of Dry Eye Syndrome","status":"COMPLETED","sponsor":"Eye & ENT Hospital of Fudan University","startDate":"2024-04-23","conditions":"Dry Eye","enrollment":30},{"nctId":"NCT07475299","phase":"NA","title":"Synbiotic Supplement With Botanical Extracts for Gut Microbiota Balance in Irritable Bowel Syndrome","status":"NOT_YET_RECRUITING","sponsor":"Iuliu Hatieganu University of Medicine and Pharmacy","startDate":"2026-04","conditions":"Irritable Bowel Syndrome (IBS)","enrollment":8},{"nctId":"NCT07224529","phase":"PHASE4","title":"Efficacy of Vevye Ophthalmic Solution for the Treatment of Meibomian Gland Dysfunction","status":"NOT_YET_RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2026-04-01","conditions":"Meibomian Gland Dysfunction (MGD)","enrollment":48},{"nctId":"NCT07471659","phase":"NA","title":"Effect of Daily Humiome® Post LB Intake on Wellbeing in Older Individuals With Moderate Stress Levels","status":"NOT_YET_RECRUITING","sponsor":"dsm-firmenich Switzerland AG","startDate":"2026-03-01","conditions":"Stress","enrollment":200},{"nctId":"NCT07471048","phase":"NA","title":"A Study to Evaluate the Impact of a Magnolia Officinalis Dietary Supplement on Immune Biomarkers in Subjects With Psoriasis","status":"RECRUITING","sponsor":"Sirt3 LLC","startDate":"2026-03-01","conditions":"Psoriasis","enrollment":100},{"nctId":"NCT07284381","phase":"PHASE3","title":"A Clinical Study to Evaluate the Effect and Side Effect of a New Artificial Tear Formulation (ABBV-444) Compared to Refresh Optive Unit Dose in Adult Participants With Dry Eye Disease","status":"RECRUITING","sponsor":"AbbVie","startDate":"2025-12-15","conditions":"Dry Eye Disease","enrollment":250},{"nctId":"NCT07469865","phase":"NA","title":"Efficacy and Safety of 20% and 100% Autologous Serum Eye Drops in Patients With Severe Dry Eye Disease (AST)","status":"COMPLETED","sponsor":"University Hospital, Ghent","startDate":"2021-11-30","conditions":"Dry Eye Disease","enrollment":46},{"nctId":"NCT07463950","phase":"PHASE4","title":"A Non-interventional Study to Evaluate the Anti-inflammatory Effects and the Clinical Efficacy of Topical Water Free Cyclosporin 0.1% Eye Drops in Patients With Dry Eye Disease and Associated Ocular Surface Inflammation Non-responding to Artificial Tears: the FOCUS Study","status":"RECRUITING","sponsor":"Medical University of Vienna","startDate":"2026-01-20","conditions":"Dry Eye Disease (DED)","enrollment":25},{"nctId":"NCT03875820","phase":"PHASE1","title":"Phase I Trial of Defactinib and VS-6766.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Institute of Cancer Research, United Kingdom","startDate":"2017-12-12","conditions":"NSCLC, Low Grade Serous Ovarian Cancer, Endometrioid Carcinoma","enrollment":87},{"nctId":"NCT05425004","phase":"PHASE2","title":"Cabozantinib for Patients With Recurrent or Progressive Meningioma","status":"RECRUITING","sponsor":"Baptist Health South Florida","startDate":"2022-06-01","conditions":"Meningioma","enrollment":24},{"nctId":"NCT05692739","phase":"PHASE4","title":"Clinical Trial To Determine The Effectiveness And Safety Of Topical Insulin In Dry Eye","status":"COMPLETED","sponsor":"Barbara Burgos Blasco","startDate":"2022-10-19","conditions":"Dry Eye, Insulin","enrollment":116},{"nctId":"NCT07075718","phase":"PHASE2, PHASE3","title":"Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant","status":"RECRUITING","sponsor":"Glaukos Corporation","startDate":"2025-06-12","conditions":"Glaucoma","enrollment":610},{"nctId":"NCT07371169","phase":"NA","title":"Efficacy of Chromium Picolinate in Reducing Acanthosis Nigricans Severity in Adolescents With Insulin Resistance","status":"COMPLETED","sponsor":"Uruk University","startDate":"2025-01-01","conditions":"Insulin Resistance, Acanthosis Nigricans","enrollment":90},{"nctId":"NCT06637423","phase":"PHASE1, PHASE2","title":"A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-12-20","conditions":"Non-Muscle Invasive Bladder Cancer","enrollment":32},{"nctId":"NCT07422259","phase":"NA","title":"Tolerability and Efficacy Study of Reinnerva/Lubristil+G vs Vismed","status":"COMPLETED","sponsor":"Medivis SRL","startDate":"2025-06-09","conditions":"Keratoconjunctivitis Sicca","enrollment":40},{"nctId":"NCT07109869","phase":"PHASE3","title":"Safety and Efficacy of Boric Acid Inserts for Treatment of Vulvovaginal Candidiasis","status":"RECRUITING","sponsor":"pH-D Feminine Health LLC","startDate":"2025-08-08","conditions":"Vulvovaginal Candidiases, Vulvovaginal Candidiasis, Genital, Vulvovaginal Candidiasis (VVC)","enrollment":400},{"nctId":"NCT07413172","phase":"PHASE2","title":"Autologous Serum Tears With Hyaluronate vs Balanced Salt Solution for Moderate-to-Severe Dry Eye","status":"NOT_YET_RECRUITING","sponsor":"University of Miami","startDate":"2026-03","conditions":"Dry Eye, Eye Diseases, Eyes Dry Chronic","enrollment":20},{"nctId":"NCT06271564","phase":"EARLY_PHASE1","title":"Effectiveness of Topical Magnetite Zinc Oxide Composite Nanoparticles in the Management of Oral Potentially Malignant Lesions","status":"RECRUITING","sponsor":"Ain Shams University","startDate":"2024-02-29","conditions":"Oral Potentially Malignant Lesions","enrollment":20},{"nctId":"NCT06425094","phase":"NA","title":"Effects of a Microalgae Extract Dietary Supplement on Gut Health, Anxiety, and Immune Function","status":"COMPLETED","sponsor":"Colorado State University","startDate":"2024-02-05","conditions":"Gastrointestinal Problem, Anxiety, Stress","enrollment":62},{"nctId":"NCT07411482","phase":"NA","title":"The Effect of Probiotic Supplementation on the Exercise Performance of Long-distance Runners.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Medical University of Gdansk","startDate":"2023-12-01","conditions":"Intestinal Microbiome, Probiotic, Runners","enrollment":27},{"nctId":"NCT06631586","phase":"PHASE2","title":"Standardized Microbiota Transplant Therapy in Crohn's Disease","status":"RECRUITING","sponsor":"University of Minnesota","startDate":"2025-01-15","conditions":"Crohn Disease","enrollment":120},{"nctId":"NCT03843385","phase":"PHASE3","title":"Transfer of FRozen Encapsulated Multidonor Stool Filtrate for Active Ulcerative COlitis","status":"RECRUITING","sponsor":"Andreas Stallmach","startDate":"2023-01-31","conditions":"Ulcerative Colitis, Inflammatory Bowel Diseases","enrollment":129},{"nctId":"NCT07264517","phase":"PHASE2","title":"Evaluating the Safety, Tolerability, and Efficacy of GRF312 5% in Participants With Dry Eye Disease (DED).","status":"RECRUITING","sponsor":"Instituto Grifols, S.A.","startDate":"2025-11-03","conditions":"Dry Eye Disease","enrollment":100},{"nctId":"NCT06045494","phase":"NA","title":"The Efficacy of Treatment for Helicobacter Pylori Infection in Preschooler by Yoghurt With LG21","status":"COMPLETED","sponsor":"Meiji China Investment Co.,Ltd","startDate":"2023-09-26","conditions":"H. Pylori Infection","enrollment":140},{"nctId":"NCT07408297","phase":"PHASE2","title":"Evaluating Safety and Immune Response of Janssen, Moderna, Pfizer/BNT, and Novavax COVID-19 Vaccines for Same and Mixed Boosters in Adolescents and Adults Aged 12-64 With and Without HIV in Kenya, DRC, and Rwanda","status":"COMPLETED","sponsor":"Victoria Biomedical Research Institute","startDate":"2022-05-18","conditions":"COVID -19, SARS CoV 2 Infection","enrollment":1919},{"nctId":"NCT06859476","phase":"PHASE4","title":"Evaluation of Manzanilla® and Meticel Ofteno® 0.5% for Providing a Relief Sensation to the Eyes","status":"COMPLETED","sponsor":"Laboratorios Sophia S.A de C.V.","startDate":"2025-05-23","conditions":"Ophthalmological Agent Toxicity","enrollment":168},{"nctId":"NCT07388576","phase":"NA","title":"A Clinical Trial to Investigate the Safety and Efficacy of AP-Brain on Cognitive Function at Varying Dosages in Healthy Younger Adults With Self-reported Attention Problems","status":"NOT_YET_RECRUITING","sponsor":"Rousselot BVBA","startDate":"2026-03","conditions":"Cognition, Cognitive Function","enrollment":120},{"nctId":"NCT07388043","phase":"NA","title":"A Clinical Trial to Investigate the Safety and Efficacy of AP-Brain on Cognitive Function at Varying Dosages in Healthy Middle-aged and Older Adults With Self-reported Memory Problems","status":"NOT_YET_RECRUITING","sponsor":"Rousselot BVBA","startDate":"2026-03","conditions":"Cognition, Cognitive Function","enrollment":120},{"nctId":"NCT07382453","phase":"PHASE2","title":"Effect of PAE Hydrogel Loaded With tRF-ASO-Exo on Patients With Diabetic Ocular Surface Diseases","status":"NOT_YET_RECRUITING","sponsor":"Affiliated Hospital of Nantong University","startDate":"2026-02-15","conditions":"Diabetic Keratopathy","enrollment":30},{"nctId":"NCT07041814","phase":"PHASE2","title":"A Study Comparing Different Treatment Approaches for the Initiation of Puberty in Girls With Turner Syndrome Using a TRIFECTA-DARED Approach for Rare Diseases","status":"NOT_YET_RECRUITING","sponsor":"Universiti Kebangsaan Malaysia Medical Centre","startDate":"2026-02-15","conditions":"Turner Syndrome","enrollment":24},{"nctId":"NCT06213649","phase":"PHASE3","title":"Parasitic Ulcer Treatment Trial","status":"RECRUITING","sponsor":"Jeremy Keenan, MD, MPH","startDate":"2024-07-01","conditions":"Acanthamoeba Keratitis","enrollment":232},{"nctId":"NCT06366087","phase":"PHASE1","title":"Sublingual Atropine Bioequivalence by Route of Administration (SABER)","status":"COMPLETED","sponsor":"Biomedical Advanced Research and Development Authority","startDate":"2024-04-15","conditions":"Atropine Bioequivalence","enrollment":46},{"nctId":"NCT05230758","phase":"PHASE3","title":"Effect of Metformin on Behaviour and the Brain in Children Treated for a Brain Tumour","status":"RECRUITING","sponsor":"Donald Mabbott","startDate":"2022-07-01","conditions":"Medulloblastoma, Childhood, Cognitive Impairment","enrollment":140},{"nctId":"NCT06428409","phase":"PHASE1, PHASE2","title":"A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-06-20","conditions":"Colorectal Cancer, Pancreatic Ductal Adenocarcinoma, Biliary Tract Cancer","enrollment":220},{"nctId":"NCT05414994","phase":"","title":"Assessment of the Ocular Microbiome in Health and Disease","status":"RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2023-09-07","conditions":"Microbial Colonization, Eye Diseases, Ophthalmopathy","enrollment":500},{"nctId":"NCT04505566","phase":"PHASE1","title":"INflammatory MediatorS in the PathophysIology of Diabetic REtinopathy Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Stephen J. Kim, MD","startDate":"2020-11-09","conditions":"Diabetic Retinopathy","enrollment":164},{"nctId":"NCT06163989","phase":"NA","title":"Protecting the Eyes of Gamers With Lubricating Eyedrops","status":"RECRUITING","sponsor":"Aston University","startDate":"2024-09-01","conditions":"Dry Eye Syndromes, Computer Vision Syndrome","enrollment":28},{"nctId":"NCT07271316","phase":"PHASE2","title":"Alii Supplement Study","status":"RECRUITING","sponsor":"Texas Christian University","startDate":"2026-01-12","conditions":"Nutrient Deficiency, Happiness, Digestive Health","enrollment":68},{"nctId":"NCT03697876","phase":"PHASE1","title":"Safety and Tolerability of the Ophthalmic Gel PRO-165 Versus Artelac® Nightime Gel","status":"COMPLETED","sponsor":"Laboratorios Sophia S.A de C.V.","startDate":"2018-08-20","conditions":"Dry Eye Syndromes","enrollment":32},{"nctId":"NCT03471143","phase":"PHASE1, PHASE2","title":"Study of IV VTS-270 for Infantile Liver Disease Associated With Niemann-Pick Disease, Type C","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2019-02-22","conditions":"Niemann-Pick Disease, Type C","enrollment":4},{"nctId":"NCT02951052","phase":"PHASE3","title":"Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected Adults","status":"ACTIVE_NOT_RECRUITING","sponsor":"ViiV Healthcare","startDate":"2016-10-28","conditions":"Infection, Human Immunodeficiency Virus, HIV Infections","enrollment":618},{"nctId":"NCT06227858","phase":"NA","title":"Effects of a Standardised Saffron Extract Supplementation on Symptoms Associated With Perimenopause in Healthy Women","status":"RECRUITING","sponsor":"Liaquat University of Medical & Health Sciences","startDate":"2025-08-20","conditions":"Perimenopausal Disorder","enrollment":104},{"nctId":"NCT05265091","phase":"PHASE1, PHASE2","title":"A Study of KL590586 in Patients With Advanced Solid Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.","startDate":"2021-09-15","conditions":"Advanced Solid Tumor","enrollment":414},{"nctId":"NCT06308653","phase":"PHASE3","title":"Psilocybin for Major Depressive Disorder (MDD)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Usona Institute","startDate":"2024-03-13","conditions":"Depressive Disorder, Major","enrollment":240},{"nctId":"NCT05632562","phase":"EARLY_PHASE1","title":"Multiparametic Metabolic and Hypoxic PET/MRI for Disease Assessment in High Grade Glioma","status":"RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2024-03-07","conditions":"High Grade Glioma","enrollment":20},{"nctId":"NCT05106127","phase":"PHASE2","title":"Safety Lead-In Study of a Repurposed Drug Added to the Combination of Len Plus Pem","status":"NOT_YET_RECRUITING","sponsor":"Evergreen Therapeutics, Inc.","startDate":"2026-08","conditions":"Advanced Endometrial Cancer","enrollment":28},{"nctId":"NCT06736366","phase":"NA","title":"Study With Two Coenzyme Q10 Products","status":"COMPLETED","sponsor":"University of Primorska","startDate":"2024-12-05","conditions":"Coenzyme Q Deficiency","enrollment":25},{"nctId":"NCT06223685","phase":"NA","title":"The Efficacy of Probiotics as an Adjunct to Treatment of SIBO With Rifaximin","status":"COMPLETED","sponsor":"Pomeranian Medical University Szczecin","startDate":"2023-04-01","conditions":"Irritable Bowel Syndrome, Small Intestinal Bacterial Overgrowth, SIBO","enrollment":129},{"nctId":"NCT05249556","phase":"PHASE3","title":"Double-blind, Randomized, Placebo-controlled Trial of Ganaxolone in CDKL5 Deficiency Patients 6 Months to Less Than 2 Years Old","status":"NOT_YET_RECRUITING","sponsor":"Immedica Pharma AB","startDate":"2026-06","conditions":"CDKL5 Deficiency Disorder","enrollment":20},{"nctId":"NCT06815653","phase":"PHASE1","title":"Digital Intervention for Psychedelic Preparation (DIPP): Comparing Meditation and Music-Based Programs","status":"RECRUITING","sponsor":"University College, London","startDate":"2025-03-01","conditions":"Healthy","enrollment":40},{"nctId":"NCT06489340","phase":"PHASE2","title":"P2a Open Label Study to Evaluate 2-HPβCD in Subjects With Diabetic Kidney Disease","status":"WITHDRAWN","sponsor":"ZyVersa Therapeutics, Inc.","startDate":"2025-06-11","conditions":"Diabetic Kidney Disease","enrollment":""},{"nctId":"NCT06968299","phase":"NA","title":"Effect of ExoBDNF Lactic Acid Bacteria Supplement on Cognitive Functions, Sleep and Psychological","status":"RECRUITING","sponsor":"SunWay Biotech Co., LTD.","startDate":"2025-05-20","conditions":"Cognitive Functions Perceptual Disturbances, Cognitive Function Abnormal, Sleep","enrollment":50},{"nctId":"NCT07240246","phase":"NA","title":"Effect of a Dietary Supplement on Hormones Involved in Appetite Regulation in Overweight and Obese Adults","status":"RECRUITING","sponsor":"FFoQSI - Austrian Competence Centre for Feed and Food Quality, Safety & Innovation","startDate":"2025-10-24","conditions":"GLP-1, Obesity &Amp; Overweight, Dietary Supplement","enrollment":40},{"nctId":"NCT07234318","phase":"","title":"Non-interventional Study to Evaluate the Anti-inflammatory Effects and the Clinical Efficacy of Topical Water Free Cyclosporin 0.1% Eye Drops in Patients With Dry Eye Disease and Associated Ocular Surface Inflammation Non-responding to Artificial Tears","status":"NOT_YET_RECRUITING","sponsor":"Laboratoires Thea","startDate":"2025-12-15","conditions":"Dry Eye Disease (DED)","enrollment":25},{"nctId":"NCT06886373","phase":"PHASE4","title":"Optimizing the Ocular Surface With Systane COMPLETE Pre- and Post-operatively in Patients With Dry Eye Planning for Cataract Surgery: An Extension Study of Optimizing the Ocular Surface With Systane COMPLETE in Patients With Dry Eye Planning for Cataract Surgery","status":"RECRUITING","sponsor":"National Taiwan University Hospital","startDate":"2025-03-25","conditions":"Ophthalmology","enrollment":140},{"nctId":"NCT05185583","phase":"PHASE2","title":"Methylphenidate in Childhood Apraxia of Speech","status":"COMPLETED","sponsor":"Murdoch Childrens Research Institute","startDate":"2022-03-14","conditions":"Childhood Apraxia of Speech","enrollment":18},{"nctId":"NCT06834984","phase":"NA","title":"Ritual Synbiotic+, a Dietary Supplement Designed to Impact Gastrointestinal Health, Mood, and Behavior in Women","status":"RECRUITING","sponsor":"Colorado State University","startDate":"2025-05-01","conditions":"Gastrointestinal Disease Symptoms","enrollment":60},{"nctId":"NCT07229001","phase":"NA","title":"Treating Meibomian Gland Disease in a Pediatric Population","status":"ENROLLING_BY_INVITATION","sponsor":"Illinois College of Optometry","startDate":"2024-10-01","conditions":"Dry Eye Disease, Meibomian Gland Disease","enrollment":15},{"nctId":"NCT02118922","phase":"","title":"A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2013-06","conditions":"Keratoconus, Ectasia, Crosslinking","enrollment":168},{"nctId":"NCT04968912","phase":"PHASE2","title":"A Study of Nipocalimab in Adults With Primary Sjogren's Syndrome (pSS)","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2021-09-21","conditions":"Sjogren's Syndrome","enrollment":163},{"nctId":"NCT05031897","phase":"PHASE2","title":"Two Step Haplo With Radiation Conditioning","status":"RECRUITING","sponsor":"Thomas Jefferson University","startDate":"2021-10-25","conditions":"Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Adult T-Cell Leukemia/Lymphoma","enrollment":63},{"nctId":"NCT01760655","phase":"PHASE2","title":"Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies","status":"COMPLETED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University","startDate":"2012-12-24","conditions":"Acute Myeloid Leukemia With FLT3/ITD Mutation, Acute Myeloid Leukemia With Gene Mutations, Acute Myeloid Leukemia With Inv(3) (q21.3;q26.2); GATA2, MECOM","enrollment":62},{"nctId":"NCT05999630","phase":"PHASE3","title":"Artificial Tears to Prevent Nasolacrimal Duct Obstruction in Patients Treated With Radioactive Iodine for Thyroid Cancer","status":"RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2023-08-21","conditions":"Nasolacrimal Duct Obstruction, Thyroid Cancer","enrollment":100},{"nctId":"NCT07078955","phase":"PHASE2","title":"A Dose Regimen Study of BRM421 Ophthalmic Solution in Patients With Dry Eye Disease","status":"NOT_YET_RECRUITING","sponsor":"BRIM Biotechnology Inc.","startDate":"2025-12","conditions":"Dry Eye Disease (DED), Keratoconjunctivitis Sicca","enrollment":99},{"nctId":"NCT07215351","phase":"NA","title":"Impact of the Inno Cleanse Dietary Supplement on Gut Health and Associated Variables in Healthy Men and Women","status":"RECRUITING","sponsor":"University of Memphis","startDate":"2025-10-07","conditions":"Constipation, Bloating","enrollment":30},{"nctId":"NCT05800353","phase":"NA","title":"Nd:YAG Laser Vitreolysis for Symptomatic Vitreous Floaters","status":"COMPLETED","sponsor":"Dongyang People's Hospital","startDate":"2022-11-22","conditions":"Weiss Ring","enrollment":70},{"nctId":"NCT04440280","phase":"PHASE2","title":"Targeting Reactive Oxygen Species Production as a Novel Therapeutic in Fuch's Endothelial Corneal Dystrophy","status":"RECRUITING","sponsor":"Massachusetts Eye and Ear Infirmary","startDate":"2020-09-16","conditions":"Fuchs Endothelial Corneal Dystrophy","enrollment":45},{"nctId":"NCT07181668","phase":"NA","title":"Effect of Low-Level Light Therapy on Ocular Surface Parameters in Patients Undergoing Femto-Lasik Surgery","status":"COMPLETED","sponsor":"Grigore T. Popa University of Medicine and Pharmacy","startDate":"2024-08-10","conditions":"Dry Eye, Meibomian Gland Dysfunction (Disorder), Ocular Surface Disease","enrollment":61},{"nctId":"NCT06191965","phase":"PHASE2, PHASE3","title":"MitoQ for Early-phase Schizophrenia-spectrum Disorder and Mitochondrial Dysfunction","status":"RECRUITING","sponsor":"Mclean Hospital","startDate":"2024-06-01","conditions":"Schizophrenia and Related Disorders, Mitochondrial Alteration, Cognitive Impairment","enrollment":100},{"nctId":"NCT06227052","phase":"PHASE4","title":"Applying Num Vapocoolant Spray to Cervix Before Paracervical Block to Decrease Pain During Gynecology Procedures","status":"COMPLETED","sponsor":"Queen's Medical Center","startDate":"2024-02-05","conditions":"Pain With Paracervical Block, Pain With Gynecology Procedure, Pain","enrollment":98},{"nctId":"NCT06876077","phase":"NA","title":"Evaluation of the Effectiveness of Auricular Acupuncture in Improving Dry Eye Symptoms in University Students","status":"COMPLETED","sponsor":"University of Medicine and Pharmacy at Ho Chi Minh City","startDate":"2025-03-15","conditions":"Dry Eye Symptoms","enrollment":50},{"nctId":"NCT04125134","phase":"PHASE4","title":"Predicting the Success of Dry Eye Disease Interventions Using Clinical Tests","status":"TERMINATED","sponsor":"Tufts Medical Center","startDate":"2019-10-03","conditions":"Dry Eye","enrollment":36},{"nctId":"NCT07185854","phase":"NA","title":"Medical vs Acupuncture for Dry Eye","status":"COMPLETED","sponsor":"Nadide Koca","startDate":"2024-01-15","conditions":"Dry Eye, Acupuncture","enrollment":90},{"nctId":"NCT05542381","phase":"NA","title":"The Role of Loteprednol in Reducing Post-Intravitreal Injection Related Pain","status":"COMPLETED","sponsor":"Virginia Polytechnic Institute and State University","startDate":"2022-12-22","conditions":"Age-Related Macular Degeneration","enrollment":64},{"nctId":"NCT07165977","phase":"NA","title":"Anti-inflammatory Probiotics in Cognitive Functioning","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Social Sciences and Humanities, Warsaw","startDate":"2024-01-25","conditions":"Memory Decline, Cognitive Decline, Cognitive Aging","enrollment":110},{"nctId":"NCT07145827","phase":"NA","title":"Effect of Metformin on Endometrial Thickness in Postmenopausal Breast Cancer Patients Receiving Tamoxifen","status":"COMPLETED","sponsor":"Uruk University","startDate":"2024-01-02","conditions":"Breast Cancer, Endometrial Hyperplasia and Endometrial Cancers","enrollment":60},{"nctId":"NCT06911073","phase":"NA","title":"A Study to Evaluate a Postbiotic in Supporting Weight Loss and Metabolic Health","status":"RECRUITING","sponsor":"ResBiotic Nutrition, Inc.","startDate":"2025-05-02","conditions":"Obesity and Overweight","enrollment":80},{"nctId":"NCT05938699","phase":"PHASE2, PHASE3","title":"Aqueous Humor Dynamics of NCX 470 Ophthalmic Solution","status":"COMPLETED","sponsor":"Nicox Ophthalmics, Inc.","startDate":"2023-12-12","conditions":"Open Angle Glaucoma","enrollment":18},{"nctId":"NCT05737342","phase":"NA","title":"Effect of ANKASCIN 568-P Products on Decreasing HbA1c and Regulating Blood Glucose","status":"RECRUITING","sponsor":"SunWay Biotech Co., LTD.","startDate":"2023-04-01","conditions":"High Blood Sugar, Metabolic Syndrome","enrollment":80},{"nctId":"NCT05737355","phase":"NA","title":"Effect of ANKASCIN 568-P Products Regulating Blood Lipid","status":"RECRUITING","sponsor":"SunWay Biotech Co., LTD.","startDate":"2023-04-01","conditions":"Hyperlipidemias","enrollment":80},{"nctId":"NCT03712878","phase":"PHASE2","title":"2-Step Approach to Stem Cell Transplant in Treating Participants With Hematological Malignancies","status":"COMPLETED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University","startDate":"2018-09-19","conditions":"Hematopoietic and Lymphoid Cell Neoplasm","enrollment":10},{"nctId":"NCT06676917","phase":"PHASE2","title":"Datopotamab Deruxtecan (Dato-DXd) for Non-Small Cell Lung Cancer (NSCLC) Patients With Active Brain Metastases","status":"WITHDRAWN","sponsor":"MedSIR","startDate":"2025-06","conditions":"Non-small Cell Lung Cancer","enrollment":""},{"nctId":"NCT04585984","phase":"NA","title":"Effect of Antioxidant Probiotic Administration on Seminal Quality and Reproductive Outcomes.","status":"COMPLETED","sponsor":"Fundación IVI","startDate":"2021-02-05","conditions":"Male Infertility","enrollment":56},{"nctId":"NCT07110467","phase":"NA","title":"Nursing Intervention of Blinking Exercises to Alleviate Dry Eye and Enhance Daily Life in Older Adults","status":"COMPLETED","sponsor":"Norther Private Collage of Nursing","startDate":"2024-11-01","conditions":"Daily Activities, Eye Health","enrollment":100},{"nctId":"NCT07064187","phase":"PHASE4","title":"Evaluate The Improvement In Symptoms Of Patients Using Cationorm After Pterygium Surgery","status":"COMPLETED","sponsor":"Nguyen Viet Giap","startDate":"2022-06-15","conditions":"Ocular Discomfort","enrollment":100}],"_emaApprovals":[],"_faersSignals":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":12,"therapeuticAreas":["Other"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"phase_1","status":"active","brandName":"Artelac","genericName":"Artelac","companyName":"Laboratorios Sophia S.A de C.V.","companyId":"laboratorios-sophia-s-a-de-c-v","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":1},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}